Issue
Alert me when new journal issues are available via or via
=free full text
Masthead page CO2 Full-Text PDF (39 KB)
Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer Lee M. Ellis pages S1-S7 Abstract | Full Text | Full-Text PDF (1653 KB)
Bevacizumab in Combination With Chemotherapy: First-Line Treatment of Patients With Metastatic Colorectal Cancer Howard S. Hochster pages S8-S14 Abstract | Full Text | Full-Text PDF (352 KB)
Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Second- and Third-Line Settings Bruce J. Giantonio pages S15-S18 Abstract | Full Text | Full-Text PDF (253 KB)
Bevacizumab in Older Patients and Patients With Poorer Performance Status Paulo M. Hoff pages S19-S25 Abstract | Full Text | Full-Text PDF (241 KB)
Bevacizumab in the Treatment of Metastatic Colorectal Cancer: Safety Profile and Management of Adverse Events Herbert Hurwitz, Shermini Saini pages S26-S34 Abstract | Full Text | Full-Text PDF (158 KB)
Combined Vascular Endothelial Growth Factor–Targeted Therapy and Radiotherapy for Rectal Cancer: Theory and Clinical Practice Christopher G. Willett, Sergey V. Kozin, Dan G. Duda, Emmanuelle di Tomaso, Kevin R. Kozak, Yves Boucher, Rakesh K. Jain pages S35-S40 Abstract | Full Text | Full-Text PDF (528 KB)
Future Directions in Vascular Endothelial Growth Factor–Targeted Therapy for Metastatic Colorectal Cancer Axel Grothey pages S41-S49 Abstract | Full Text | Full-Text PDF (410 KB)
Frontmatter
Contents page A1 Full-Text PDF (31 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
